DMT and Ayahuasca Student Educational Slides

Ayahuasca has been used as a medicine in Mesoamerican ceremonies for thousands of years, but the primary psychoactive compound, DMT, was not synthesised until 1931. DMT was studied during the wave of psychedelic research in the 1950s and 60s until research was banned in 1971 by the Convention of Psychotropic Substances. Ayahuasca was not included  …


Ending the pain of children with severe epilepsy?

An audit of the impact of medical cannabis in 10 patients with severe epilepsy. Background Scientific and anecdotal evidence suggest that whole-plant cannabis extracts are effective in reducing seizure frequency in individuals with a range of epileptic etiologies. We report a case series of 10 individuals using CBMPs in the UK to treat their conditions.  …


2019: A year of expansion in psychedelic research, industry, and deregulation

Public and scientific interest into psychedelic drugs has grown steadily over much of the last two decades, before an exponential increase in recent years. We contend that 2019, in particular, involved myriad notable changes in the science, industry, and deregulation of psychedelic drugs. However, it is becoming increasingly difficult for professionals to keep up-to-date on  …


Improved colour blindness symptoms associated with recreational psychedelic use

It is well documented that psychedelic drugs can have a profound effect on colour perception. After previous research involving psychedelic drug ingestion, several participants had written to the authors describing how symptoms of their colour blindness had improved. The Global Drugs Survey runs the world’s largest annual online drug survey. In the Global Drugs Survey  …


So near yet so far: why won’t the UK prescribe medical cannabis?

This Drug Science research was published in the British Medical Journal Open, you can download the full report here. In November 2018 when the UK made cannabis-based products for medicinal use (CBPMs) legal most people assumed these would immediately be made available to patients, but they were wrong. In the year since almost no National  …


Medical cannabis in the UK: From principle to practice

Read the full paper here (open access) Drug Science submits it’s finding concerning the UK Medical cannabis industry. In our recent peer-reviewed publication, Drug Science examines the current barriers to prescribing medical cannabis; ethical issues that arise from that process and we present our recommendations for best practice within this space. In the UK, medical  …